Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IEMG vs GSK✓SelectedUSD · GSKIEMG vs GSK performance historyLatest closeAs of-0.96%11/17
Stock and ETF performance explorer

IEMG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+29.8%
GSK return
+43.9%
Excess return
-14.1%
Maximum drawdown
-31.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.0%-2.3%+1.4%-0.6%
7D-3.6%-3.0%-0.6%-3.2%
30D-7.4%+0.4%-7.8%-7.5%
3M-13.3%-1.2%-12.1%-13.2%
6M-9.9%+0.9%-10.8%-10.4%
YTD+6.6%+4.0%+2.6%+5.3%
1Y+8.7%+7.3%+1.4%+6.7%
3Y+57.3%+57.1%+0.3%+40.5%
5Y+29.8%+43.0%-13.1%+11.5%
All+29.8%+43.9%-14.1%+11.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling